Drug delivery and nanoparticles: Applications and hazards

Abstract

Abstract:The use of nanotechnology in medicine and more specifi cally drug delivery is set to spread rapidly. Currently many substances are under investigation for drug delivery and more specifi cally for cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient. The kind of hazards that are introduced by using nanoparticles for drug delivery are beyond that posed by conventional hazards imposed by chemicals in classical delivery matrices. For nanoparticles the knowledge on particle toxicity as obtained in inhalation toxicity shows the way how to investigate the potential hazards of nanoparticles. The toxicology of particulate matter differs from toxicology of substances as the composing chemical(s) may or may not be soluble in biological matrices, thus infl uencing greatly the potential exposure of various internal organs. This may vary from a rather high local exposure in the lungs and a low or neglectable exposure for other organ systems after inhalation. However, absorbed species may also infl uence the potential toxicity of the inhaled particles. For nanoparticles the situation is different as their size opens the potential for crossing the various biological barriers within the body. From a positive viewpoint, especially the potential to cross the blood brain barrier may open new ways for drug delivery into the brain. In addition, the nanosize also allows for access into the cell and various cellular compartments including the nucleus. A multitude of substances are currently under investigation for the preparation of nanoparticles for drug delivery, varying from biological substances like albumin, gelatine and phospholipids for liposomes, and more substances of a chemical nature like various polymers and solid metal containing nanoparticles. It is obvious that the potential interaction with tissues and cells, and the potential toxicity, greatly depends on the actual composition of the nanoparticle formulation. This paper provides an overview on some of the currently used systems for drug delivery. Besides the potential benefi cial use also attention is drawn to the questions how we should proceed with the safety evaluation of the nanoparticle formulations for drug delivery. For such testing the lessons learned from particle toxicity as applied in inhalation toxicology may be of use. Although for pharmaceutical use the current requirements seem to be adequate to detect most of the adverse effects of nanoparticle formulations, it can not be expected that all aspects of nanoparticle toxicology will be detected. So, probably additional more specifi c testing would be needed.

Nanodrug applications in photodynamic therapy

“…More importantly the question of long term effects is often neglected. As pointed out in a recent review by De Jong and Borm "the lessons learned from particle toxicity as applied in inhalation toxicity" should be taken into account [44]. In fact, many toxic effects of nanoparticles have been noted.…”

Targeted delivery of mesoporous silica nanoparticles loaded monastrol into cancer cells: an in vitro study

“…The porosity and shape of MSNPs accommodate the drug molecules. Therefore, for the effective drug loading and its delivery to the targeted sites, MSNPs are selective to capture bigger bioactive molecules in substantial amount (Jong and Borm 2008;Jaganathana and Godin 2012).…”

An Apoferritin‐based Drug Delivery System for the Tyrosine Kinase Inhibitor Gefitinib

“…Currently various approaches are considered to develop effi cient drug delivery systems. [ 1,2 ] Leaky vasculature, associated with sustained tumor angiogenesis together with tumor-associated poor lymphatic drainage can enhance passive targeting of nanoparticles (NPs) to malignant tissue resulting in the enhanced permeability retention effect. [ 3,4 ] Nanoparticulate drug formulations, exploiting this feature of the tumor microenvironment, can be used to deliver chemotherapeutic agents to tumor target sites thereby increasing the therapeutic effect while minimizing systemic toxicities.…”

“…[ 1,6 ] Human ferritin is an ideal drug delivery carrier due to the nanoscale structure, and biocompatible, biodegradable, stable, nontoxic properties. [ 2,7,8 ] Ferritin consists of an apoferritin (AFt) protein cage and an iron core, and prevents accumulation of toxic levels of free iron in cells. AFt is composed of 24 subunits arranged into a 12 nm diameter cage with an internal 8 nm cavity.…”